: NF-κB is elevated in breast tumors after therapy (IMAGE)
Caption
Compared with an untreated breast tumor (left), NF-κB (brown) is elevated in a residual tumor after therapy (right) due to a softening of the extracellular matrix. NF-κB promotes the cancer cells' survival and subsequent tumor relapse.
Credit
©2021 Drain et al. Originally published in <em>Journal of Experimental Medicine</em>. https://doi.org/10.1084/jem.20191360
Usage Restrictions
Reporters may freely use these materials in news coverage with the appropriate credit information.
License
Licensed content